AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$2,719
-5.74%
Shares
Shares Volume: 2,029 Shares
Average Share Price: $1.34
INSIDER
Prior Stephen David
Chief Strategy Officer (Officer)
reported on Jan 7 2025
traded on Jan 3 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 33,313 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $2,718.86 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 7 / 11 |
| P/S VALUE RATIO | 0.207 |
| AVERAGE SALE VALUE | $902,257.28 |
| COMPANY PREVIOUS TRADES |